Dianthus Therapeutics
DNTH
DNTH
50 hedge funds and large institutions have $23.4M invested in Dianthus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-2
Holders Change %
-3.85%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
10
Reduced
10
Closed
14
Calls
$12K
Puts
$9K
Net Calls
+$3K
Net Calls Change
-$5K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DTC
51
Deep Track Capital
Greenwich,
Connecticut
| – | -$1.19M | -187,500 | Closed |
|
52
Millennium Management
New York
| – | -$914K | -144,597 | Closed |
|
53
Adage Capital Partners
Boston,
Massachusetts
| – | -$343K | -54,291 | Closed |
|
|
IHAM
54
Integral Health Asset Management
New York
| – | -$164K | -26,000 | Closed |
|
|
BL
55
Bleichroeder LP
New York
| – | -$137K | -21,664 | Closed |
|
56
Dimensional Fund Advisors
Austin,
Texas
| – | -$60 | -9,562 | Closed |
|
57
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
| – | -$47K | -8,087 | Closed |
|
58
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$29.9K | -4,738 | Closed |
|
59
Goldman Sachs
New York
| – | -$15K | -2,379 | Closed |
|
|
EGM
60
Engineers Gate Manager
New York
| – | -$13.5K | -2,131 | Closed |
|
|
E
61
Ergoteles
New York
| – | -$8.61K | -1,363 | Closed |
|
|
SG
62
StoneX Group
New York
| – | -$4.83K | -765 | Closed |
|
63
Citigroup
New York
| – | -$291 | -46 | Closed |
|